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Abstract We have investigated the involvement of MAP kinase 
cascades in the response of the liver to post-ischemic reperfusion. 
Both JNKs and ERKs are activated but the duration and 
magnitude of the increase in their activities appear to be 
different. JNK activation is more marked but shorter than that 
of ERKs. The increase observed in the phosphotyrosine content 
of the 52 kDa Shc protein, accompanied by an increased amount 
of co-immunoprecipitated Grb2, and the activation of Raf-1 
kinase provide evidence of the involvement of a Ras-Raf- 
dependent pathway, with a time course that is similar to that of 
ERK activation. The treatment of rats with IL-1 receptor 
antagonist modified all of the described effects, suggesting that 
IL-1 plays a role in the response of the liver to reperfusion. 
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1. Introduction 
Mitogen-activated protein kinases (MAPKs) are Ser/Thr 
kinases that convert extracellular stimuli to intracellular sig- 
nals controlling ene expression [1]. Extracellularly regulated 
kinases (ERKs), the best studied members of the MAPK fam- 
ily, are rapidly activated upon stimulation of cell surface re- 
ceptors and play a central role in proliferation and differentia- 
tion [2]. The most recently identified members of the MAPK 
family [3], the c-Jun NH2 terminal kinases (JNKs), are in- 
duced by a variety of stimuli including heat shock, ultraviolet 
radiation, protein synthesis inhibitors and inflammatory cyto- 
kines such as IL-1 and TNF [3-5]. Both ERKs and JNKs 
phosphorylate and activate nuclear proteins [6]. ERKs regu- 
late Elkl [7], which controls the expression of c-fos and other 
genes [8], and JNKs phosphorylate the amino-terminal trans- 
activating domain of Jun and ATF2, increasing their tran- 
scriptional activity [9]. 
Liver ischemia can cause severe cell damage without leading 
to cell death if not too prolonged [10]. On the other hand, 
reperfusion can induce oxidative stress [11], the release of 
proinflammatory c tokines by Kupffer cells [12,13] and var- 
ious biochemical processes [14] including the reprogramming 
of gene expression with a rapid induction of c-fos, c-jun and 
stress genes [15]. As for the signaling pathways controlling 
these transcriptional events we demonstrated that PKC activ- 
ity is reduced for many hours after post-ischemic reperfusion 
[16]. In the present study, based on the regulatory role of the 
MAPK cascades in gene expression, the activation of MAPKs 
upon heat shock of the liver in vivo [17] and the similarities in 
gene reprogramming during heat shock and post-ischemic re- 
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perfusion of liver [18], we investigated the possible involve- 
ment of JNK and ERKs in the liver's response to reperfusion. 
2. Materials and methods 
2.1. Materials 
MEKl-[K97A], anti-MAPK R2, and anti-Shc polyclonal antibodies 
were from Upstate Biotechnology Inc. (Lake Placid, NY, USA). Anti- 
Raf-1 (C-12) and anti-JNK1 polyclonal antibodies, GST-Jun (aa 1- 
79) were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). 
Anti-Grb2 and anti-phosphotyrosine (RC 20) monoclonal ntibodies 
were from Transduction Laboratories (Lexington, KY, USA). Human 
recombinant IL-1 receptor antagonist (IL-1 RA), expressed in Bacillus 
subtilis, of 98% purity, 1 × 106 IU/mg, was a kind gift of Diana Bo- 
raschi, Centro Ricerche Domp+, L'Aquila (Italy). Myelin basic pro- 
tein (MBP) and all other reagents were from Sigma Chem. Co. (St. 
Louis, MO, USA). 
2.2. Animals and treatment 
Male Wistar rats of 250 g, housed and handled as prescribed by EC 
regulations, were used throughout and were subjected to partial iver 
ischemia of 1 h duration as described [10]. After different imes of 
reperfusion the rats were killed, the livers were rapidly excised and 
deep frozen. IL-1 RA, diluted with sterile saline, was injected intra- 
peritoneally at total doses ranging from 100 l.tg to 400 ~tg per 100 g 
body weight, given in two equal portions; the first 30 min before 
ischemia, the second at the removal of the clamp. 
2.3. JNK immunocomplex kinase assay 
Livers were lysed in RIPA buffer containing: 0.15 M NaC1, 50 mM 
Tris pH 7.4, 1% deoxycholic acid, 1% Triton X-100, 0.1% SDS, 2 ~tg/ 
ml aprotinin, 40 I.tg/ml bestatin, 0.5 I.tg/ml eupeptin, 1 mM phenyl- 
methylsulfonyl fluoride (PMSF), 0.7 ~tg/ml pepstatin A, 20 mM ~- 
glycerophosphate, 50 ~tM sodium orthovanadate, 10 mM p-nitro- 
phenol phosphate (PNPP), which makes it possible to obtain highly 
reproducible r sults minimizing loss of enzyme activity [19]. 300 Ixg of 
proteins of lysates were incubated with 5 gg of anti-JNK1 antibody or 
with 5 lal of preimmune s rum for 1 h at 4°C and adsorbed to protein 
A Sepharose. After several washes, immunoprecipitates were incu- 
bated for 20 min at 30°C in 50 lal of reaction mixture containing: 
20 mM HEPES pH 7.4, 20 mM 13-glycerophosphate, 10 mM MgCI~, 
10 mM PNPP, 1 mM dithiothreitol (DTT), 50 ~tM sodium orthova- 
nadate, 20 ~tM ATP, 10 ~tCi [y-32p]ATP and 2 ~tg of GST-Jun contain- 
ing Ser-63 and -73, specific phosphorylation sites for JNK [4]. Kinase 
reactions were stopped with Laemmli's buffer [20] and the samples 
were resolved by 10% sodium dodecyl sulfate polyacrylamide g l elec- 
trophoresis (SDS-PAGE). The radioactivity incorporated into GST- 
Jun was detected by autoradiography and evaluated by densitometric 
analysis. 
2.4. ERK immunocomplex kinase assay 
300 ~tg of cytosolic proteins were subjected to immunoprecipitation 
with 4 ~tg of anti-MAPK R2 antibody or 5 Ixl of preimmune serum 
and the immunoprecipitates w re assayed for their capacity to phos- 
phorylate the MBP in the presence of [7-32p]ATP as previously de- 
scribed [21]. MBP phosphorylation, detected by SDS-PAGE and 
autoradiography, was evaluated by densitometric analysis. 
2.5. Immunoprecipitation f Shc proteins 
Immune complexes were obtained as described [17]. Briefly, 1 mg of 
proteins of lysates were incubated with 3 ~tg of polyclonal anti-Shc 
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antibody for 5 h at 4°C and adsorbed to protein A Sepharose. Im- 
munoprecipitates were extensively washed and resuspended in 
Laemmli's buffer [20] for successive immunoblot analysis. 
2.6. Raf-1 immune complex kinase assay 
Livers were lysed in RIPA buffer containing: 20 mM Tris-HC1 pH 
8, 137 mM NaC1, 10% glycerol, 1% Nonidet P-40, 0.1% sodium de- 
oxycholate, 2 mM EDTA, 1 mM PMSF, 1 mM aprotinin, 20 gM 
leupeptin, 5 mM sodium orthovanadate and 50 mM NaF, which 
allows an excellent solubilization of the Raf-1 protein and prevents 
co-immunoprecipitation of associated kinases [22]. 500 gg of proteins 
of lysates were incubated with 1.5 p.g of anti-Raf-1 antibody or with 
5 gl of preimmune serum for 3 h at 4°C and adsorbed to protein A 
Sepharose. After several washes, immunoprecipitates were incubated 
for 20 min at 25°C in 50 gl of kinase buffer containing: 30 mM 
HEPES pH 7.4, 7 mM MnC12, 5 mM MgC12, 1 mM DTT, 15 gM 
ATP, 20 gCi of [y-32p]ATP and 1 I.tg of MEKl-[K97A] as specific 
substrate. Kinase reactions were stopped with electrophoresis buffer 
and the MEK1 phosphorylation detected, by SDS-PAGE and auto- 
radiography, was evaluated by densitometric analysis. 
2.7. Procedure controls 
Optimal conditions for immunoblotting and immunoprecipitation 
reactions had been defined by preliminary experiments in which dif- 
ferent amounts of proteins were probed with different amounts of 
antibodies. Further, the experiments of immunoprecipitation were oc- 
casionally accompanied by assays of reprecipitation of the superna- 
tants with the same antibody to verify that the immunoprecipitation 
was complete. The specificity of the immunoprecipitates and of the 
kinase reactions was always evaluated by verifying that preimmune 
serum did not precipitate proteins reacting with specific antibodies or 
phosphorylating specific substrates. All phosphorylation reactions 
were studied within their linear range determined by pilot experiments 
of time course performed in the described conditions. 
2.8. lmmunoblot analysis 
SDS-PAGE and Western blotting were performed as described ear- 
lier [21]. Blots were developed using the enhanced chemiluminescent 
method. 
2.9. Other procedures 
The protein content was estimated by Bradford's method [23] using 
BSA as standard. Quantitative measurements of immunoreactive or 
radioactive bands was performed by densitometric analysis using Im- 
age Master software (Pharmacia, Milwaukee, WI, USA). Means 
+S.E.M. of volumetric measurements (OD×mm 2) of at least three 
separate xperiments were compared with Student's t-test. 
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Fig. 1. Time-dependent effect of post-ischemic liver reperfusion on 
JNK activity. Detection of phosphorylated GST-Jun was done by 
resolving whole immune complex kinase assays by SDS-PAGE and 
autoradiography. The autoradiograph is representative of three 
separate xperiments. Along the bottom, the values of quantitative 
analysis are reported. *P< 0.01 vs. control. 
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Fig. 2. Time-dependent effect of post-ischemic liver reperfusion on 
ERKs. a: Immunoblot analysis of liver extract proteins with anti- 
MAPK antibody representative of three separate xperiments, b: 
Autoradiograph of SDS-PAGE of the ERK immune complex kinase 
assays. Along the bottom, the values of quantitative analysis of 
MBP phosphorylation of three separate xperiments are reported. 
*P < 0.05 vs. control. 
3.  Resu l t s  
The effects of post-ischemic liver reperfusion were com- 
pared with observations made in normal rats, since sham op- 
erations and ischemia did not modify parameters under study. 
3.1. JNK activity during post-ischemic liver reperfusion 
Reperfusion caused a remarkable significant activation of 
JNK-1. GST-Jun phosphorylation by immunoprecipitated 
JNK  became respectively 12 and 10 times the control value 
at 30 rain and 1 h of reperfusion; the effect disappeared after 
2 h (Fig. 1). 
3.2. ERK activity during post-ischemic liver reperfusion 
We first analyzed the electrophoretic behavior of ERKs by 
immunoblotting experiments ince their activation results in 
mobility shifts of the enzymes [24]. Ant i -MAPK R2 antibod- 
ies correctly detected two proteins of 44 and 42 kDa, corre- 
sponding to ERK 1 and ERK 2 proteins in liver extracts from 
control animals. After ischemia, the restoration of blood sup- 
ply caused a decrease in the electrophoretic mobility of a part 
of both isoenzymes that was already evident after 30 min, was 
maintained for 1 and 2 h, and disappeared after 4 h (Fig. 2a). 
We also investigated the enzyme activity by immune com- 
plex kinase assay. The autoradiograph in Fig. 2b shows the 
MBP phosphorylation obtained in a typical experiment. Den- 
sitometric analysis of three different experiments showed that 
the amount of zzp incorporated into MBP was significantly 
increased after 30 min of reperfusion, reaching values that 
were 3 times higher than the controls. The effect was main- 
tained at the same level after 1 and 2 h of reperfusion, return- 
ing to basal level at 4 h. 
3.3. Shc protein involvement during post-ischemic liver 
reperfusion 
By immunoblot analysis of Shc immunoprecipitates, we 
found that anti-Shc antibodies recognized the 66, 52 and 46 
kDa isoforms of Shc proteins in the livers of control rats, and 
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Fig. 3. Time-dependent effect of post-ischemic liver reperfusion on (a) the pattern of immunoprecipitated She proteins, (b) the tyrosine phos- 
phorylation of immunoprecipitated Sheproteins and (c) the amount of co-immunoprecipitated Grb2. TCL = total cellular lysate. Quantitative 
analysis of three separate experiments i  reported along the bottom; the values in (a) refer to the 52 She protein. *P < 0.05 vs. control. 
the reperfusion did not modify their amount (Fig. 3a). After 
the stripping of the anti-Shc antibodies, the same blots were 
probed with anti-phosphotyrosine antibodies (Fig. 3b). In 
control animals the 52 kDa Shc protein had a basal level of 
phosphotyrosine content which significantly increased 2-fold 
after 30 min of reperfusion. This effect was maintained for 2 h 
and disappeared after 4 h. Tyrosine phosphorylation never 
involved the 66 and 46 kDa isoforms of Shc proteins. Finally 
by probing the same blots with anti-Grb2 antibodies (Fig. 3c) 
we detected that the amount of Grb2 precipitated with Shc 
proteins was 2-fold the normal value after 30 min of reperfu- 
sion. This significant effect was maintained until 2 h and dis- 
appeared at 4 h of reperfusion. 
3.4. Effect of post-ischemic liver reperfusion on Raf-1 
We examined Raf-1 electrophoretic mobility by immuno- 
blot experiments (Fig. 4a). In total liver extracts from control 
animals, a polyclonal anti-Raf-1 antibody detected a 74 kDa 
protein, as reported for c-Raf-1 [25]. After 30 min of reperfu- 
sion, Raf-1 showed a shift in its electrophoretic mobility 
which was maintained for 1 and 2 h, and disappeared after 
4 h of reperfusion. Raf-1 kinase activity was studied by im- 
munocomplex kinase assay and the autoradiograph in Fig. 4b 
shows the MEK1 phosphorylation obtained in a typical ex- 
periment. We found that Raf-1 activity increased at 30 min, 
reaching significant values after 1 and 2 h of reperfusion, 
when it was 2-fold the control value. MEK1 phosphorylation 
returned to basal level after 4 h. 
of Grb2 co-immunoprecipitated with She proteins was de- 
tected (Fig. 5d). Lower doses did not have any effect. 
4. D iscuss ion  
The present results show that post-ischemic liver reperfu- 
sion rapidly activates both JNKs and ERKs. Although the 
separate activation of JNK and ERK is associated with stress 
and growth signals, respectively, the concomitant induction of 
both enzymes has also been frequently observed [28,29]. In 
our experimental model, although the time necessary for the 
activation of the two enzymes eemed to be the same, dura- 
tion and magnitude of the increase in enzymatic activities 
appeared to be different, since the activation of JNKs was 
more marked but shorter than that of ERKs. It has been 
demonstrated that the duration of JNK and ERK activation 
may be responsible for the quality of cell responses. Persistent 
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3.5. Effects of IL-I receptor antagonist treatment 
To assess the possible role of IL-I in the induction of the 
MAPK cascades during post-ischemic reperfusion, we pre- 
treated the rats with IL-1 RA [26], which can prevent the 
binding of IL-lct and IL-I~ to the cells [27]. All observations 
were made after 30 min of reperfusion. IL-1 RA at a dose of 
400 p.g/100 g b.wt. reduced the increase in Jun phosphoryla- 
tion induced by reperfusion by 50%, whereas the doses of 100, 
200, and 300 l.tg/100 g b.wt. had no effect (Fig. 5a). The study 
of the electrophoretic behavior of ERKs showed that IL-1 RA 
at a dose of 400 ~tg/100 g b.wt. decreased by 50% the extent of 
the ERK 2 mobility shift due to reperfusion; lower doses did 
not have any effect (Fig. 5b). Finally the increase in phospho- 
tyrosine content of the 52 kDa She protein upon reperfusion 
was reduced by about 40% when the IL-1 RA dose was 400 
~tg/100g b.wt. (Fig. 5c). A comparable decrease in the amount 
b 
o I. 
Mean 7.63 10.62 15.71" 14.33" 6.86 
± S.E.M. :I: 0.83 ± 1.20 ± 1.02 ± 1.70 ± 0.80 
Fig. 4. Time-dependent effect of post-ischemic liver reperfusion on 
Raf-1 kinase, a: Immunoblot analysis of liver extract proteins with 
anti-Raf-1 antibody, representative of three separate xperiments. 
The dashed arrow indicates the electrophoretic mobility shift of 
Raf-1. b: Autoradiograph of SDS-PAGE of the Raf-1 immune 
complex kinase assays. Along the bottom, the values of quantitative 
analysis of Mekl phosphorylation in three separate xperiments are 
reported. *P< 0.05 vs. control. 
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Fig. 5. Effects of different doses of IL-1 RA on the response of the liver to reperfusion, a: GST-Jun phosphorylation byJNK immunocomplex 
kinase assay, b: Immunoblot analysis of ERKs from liver extract proteins, c and d: Immunoblot analysis of Shc immunoprecipitates with anti- 
phosphotyrosine and antioGrb2 antibodies, respectively. Along the bottom of each panel the results of densitometric analysis of three different 
experiments are reported, limited to the samples howing a significant effect of IL-I RA. The values in (b) refer to the ERK 2 shift. *P<0.05 
vs. control, °P<0.05 vs. reperfusion with no IL-1 RA. 
JNK activation has been described in Jurkat T cells after 
apoptosis-inducing treatment [30], whereas transient activa- 
tion is universal in JNK responses to stress [31]. In PC12 cells, 
transient ERK activation is associated with a proliferative 
response, while persistent activation leads to a differentiative 
response [32]. The behavior of JNK and ERK activity in our 
experimental model is consistent with a condition of cell re- 
pair without proliferation or apoptosis. JNK and ERK acti- 
vation is currently believed to involve two separate but inter- 
connected pathways [1]: MEKK1, which lies on the JNK 
pathway, may be an effector of Ras [33], which lies on the 
ERK pathway; likewise, ceramide-activated protein kinase 
(CAPK), which is mostly involved in JNK activation [34], 
may phosphorylate Raf and lead to ERK activation [35]. 
Furthermore, Ras could be a regulatory factor for both ki- 
nases, as it is located upstream of Raf and, according to some 
observations, also upstream of Rho/Rac [36], whose activa- 
tion leads to activation of JNKs [37]. Therefore, Ras-depend- 
ent as well as Ras-independent pathways may exist for ERKs 
and JNKs, and a Ras-independent-Raf-dependent pathway 
may lead to ERK activation. Ras may be activated as a con- 
sequence of the tyrosine phosphorylation of Shc proteins: 
these phosphotyrosine r sidues, acting as recognition sites 
for binding of the Grb2-Sos complex [38], lead to Ras activa- 
tion triggering the GDP-GTP exchange reaction [39]. We 
found that the tyrosine phosphorylation f Shc proteins, func- 
tional to the recruitment of Grb2, occurs during post-ischemic 
liver reperfusion suggesting that Ras is induced. Although we 
cannot exclude the possibility that Ras may be involved in 
activation of both JNKs and ERKs, the observation that Ras 
activating events and Raf-1 kinase are still operating after 2 h 
of reperfusion (when ERKs but not JNKs are activated) sug- 
gests that a Ras-Raf-dependent pathway primarily controls 
the ERK cascade. 
Our results showing that IL-1 RA treatment lessens the 
effects of liver reperfusion suggest that IL-1 plays a pleiotropic 
role in the activation of the MAPK cascades, since it modu- 
lates JNKs,  ERKs, and Shc tyrosine phosphorylation. Finally, 
the partial effects of IL-1 RA treatment on liver responses to 
reperfusion are consistent with the release of TNF-~ and IL-6 
(in addition to IL-1) by Kupffer cells observed uring post- 
ischemic liver reperfusion [12], and with the possible interven- 
tion of other pathophysiological f ctors such as ATP and 
substrate depletion. 
As a whole, our results indicate that liver reperfusion after 
non-necrogenic is hemia rapidly triggers the MAPK cascades 
involving both JNKs  and ERKs by a mechanism that is 
mediated, at least in part, by IL-1. As many important sub- 
strates for these enzymes are transcription factors, we propose 
that JNKs and ERKs play a role in the genomic response of 
the liver to reperfusion; the interactions between them and 
between their transcriptional factor targets might be an im- 
portant modulatory mechanism allowing reperfusion-specific 
gene expression. 
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